Compare TOI & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | SLDP |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | 641 | 230 |
| Industry | Medical/Nursing Services | Electrical Products |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 535.5M |
| IPO Year | N/A | N/A |
| Metric | TOI | SLDP |
|---|---|---|
| Price | $5.87 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $7.00 |
| AVG Volume (30 Days) | 1.8M | ★ 4.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | N/A |
| Revenue Next Year | $25.77 | $48.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.32 | $2.32 |
| 52 Week High | $6.11 | $8.86 |
| Indicator | TOI | SLDP |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 32.38 |
| Support Level | $3.28 | N/A |
| Resistance Level | N/A | $3.53 |
| Average True Range (ATR) | 0.37 | 0.15 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 78.10 | 0.77 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.